TherapeuticsMD (TXMD) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2023)
TherapeuticsMD (TXMD) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.84% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -11.73% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 7.65% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.86% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 27.15% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -6.48% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 11.32% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.90% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 28.35% |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -78.71% |
| Jun 30, 2023 | -73.71% |
| Mar 31, 2023 | -70.80% |
| Dec 31, 2022 | -68.55% |
| Sep 30, 2022 | -38.23% |
| Jun 30, 2022 | -20.85% |
| Dec 31, 2021 | 20.30% |
| Sep 30, 2021 | 53.75% |
| Jun 30, 2021 | 59.80% |
| Mar 31, 2021 | 62.08% |
| Dec 31, 2020 | 64.40% |
| Sep 30, 2020 | 63.82% |
| Jun 30, 2020 | 64.32% |
| Mar 31, 2020 | 65.82% |
| Dec 31, 2019 | 69.30% |
| Sep 30, 2019 | 71.87% |
| Jun 30, 2019 | 47.71% |
| Dec 31, 2018 | 33.52% |
| Sep 30, 2018 | 88.80% |
| Dec 31, 2017 | 90.43% |